Read about Endologix
in the news

Embrace the evidence.

The Latest:

One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)

See Release

All News

Archives

Endologix Announces 150th Patient Enrolled in JAGUAR Randomized Controlled Trial

Endologix Wins “Medical Device Engineering Breakthrough” Award in 7th Annual MedTech Breakthrough Awards Program

Five-Year Results of the LEOPARD Trial published in the Journal of Vascular Surgery (JVS)

Endologix Receives FDA Approval of PMA Supplement for AFX2 System

Endologix Announces 12-Month Results of DETOUR-2 Trial at 2022 VIVA Late-Breaking Clinical Trial Session